author-photo

William L. Redmond

Providence Portland Medical Center

91

Papers

2797

Citations

Citation Trend

Filter By

Papers (67) Sort By

Journal Conference Others

Arginase therapy combines effectively with checkpoint blockade or agonist anti-OX40 immunotherapy to control tumor growth.

2021 Cancer immunology research
Show All
- Source
- Cite
- Save
Citations (1)
Developing an enhanced 7-color multiplex IHC protocol to dissect immune infiltration in human cancers.

2021 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (7)
Unaltered IL-2 encapsulated in acoustically active lipid microspheres for systemic but targeted microdose delivery to tumor microenvironment.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
94 Effects of chemoimmunotherapy on the peripheral blood: insights from immune monitoring of a phase Ib trial of pembrolizumab and paclitaxel or capecitabine for triple-negative breast cancer (TNBC)

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Multiplex immunofluorescence to measure dynamic changes in tumor-infiltrating lymphocytes and PD-L1 in early-stage breast cancer.

2021 Breast Cancer Research
Show All
- Source
- Cite
- Save
Citations (13)
Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor.

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (4)
Abstract 1665: QuPath versus InForm: Digital image analysis of multiplex immunofluorescence (mIF) tumor-infiltrating lymphocyte (TIL) outcomes in an immunotherapy clinical trial

2021 Immunology
Show All
- Source
- Cite
- Save
Citations (0)
596 Combining Bempegaldesleukin (CD122-preferential IL-2 pathway agonist) and NKTR-262 (TLR7/8 agonist) pairs local innate activation with systemic CD8+ T cell expansion to enhance anti-tumor immunity

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
399 A phase II study of nivolumab, ipilimumab, plus androgen receptor blockade with bicalutamide to enhance thymic T-cell production and immunotherapy response in metastatic breast cancer

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
760 Trough levels of ipilimumab in serum as a potential predictive biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)